IBRN
iShares Neuroscience and Healthcare ETF · PSE
- Category Health Care
- Expense Ratio 0.47%
- Listing Date Aug 26, 2022
- Volume 242.0
- Market Cap (AUM) $3.82M
Performance
-1.29%
1W
-0.81%
1M
+0.25%
3M
+11.0%
6M
-2.53%
YTD
+5.43%
1Y
Top Holdings
-
Name
Symbol%Assets
- PTC Therapeutics, Inc.PTCT5.33%
- Intra-Cellular Therapies, Inc.ITCI5.05%
- Cerevel Therapeutics Holdings IncCERE4.88%
- Biogen Inc.BIIB4.84%
- Neurocrine Biosciences, Inc.NBIX4.77%
- Axonics, Inc.AXNX4.77%
- argenx SE ADRARGX4.60%
- Sarepta Therapeutics, Inc.SRPT4.37%
- Alkermes Public Limited CompanyALKS3.86%
- Integra LifeSciences Holdings CorporationIART3.85%
Technical Analysis of IBRN 2024-12-19
Technical Scores and Rating
Moving Average Score
Oscillator Score
Technical Rating
Recent News & Updates
Page 1 of 1
previousnext
Disclaimer: The information provided here and on kavout.com site is for general informational purposes only. It does not constitute investment advice, financial advice, trading advice, or any other sort of advice. Kavout does not recommend that any investment decision be made based on this information. You are solely responsible for your own investment decisions. Please conduct your own research and consult with qualified financial advisors before making any investment. Kavout and its partners are participants in a number of affiliate advertising programs. As an Amazon Associate, Kavout or its partners earn from qualifying purchases from affiliate links. We also participate in other affiliate and advertising programs that provide a means for us to earn advertising fees by advertising and linking to third-party websites.